Singapore markets closed

Tandem Diabetes Care, Inc. (0M0F.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
24.34+1.10 (+4.73%)
At close: 06:55PM GMT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 3-39.13%
S&P500 52-week change 314.91%
52-week high 344.34
52-week low 313.89
50-day moving average 318.76
200-day moving average 328.39

Share statistics

Avg vol (3-month) 3551
Avg vol (10-day) 3421
Shares outstanding 557.37M
Implied shares outstanding 6N/A
Float 859.25M
% held by insiders 10.63%
% held by institutions 1109.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -27.02%
Operating margin (ttm)-16.99%

Management effectiveness

Return on assets (ttm)-8.51%
Return on equity (ttm)-56.66%

Income statement

Revenue (ttm)771.42M
Revenue per share (ttm)11.92
Quarterly revenue growth (yoy)-9.30%
Gross profit (ttm)412.99M
EBITDA -119.95M
Net income avi to common (ttm)-208.46M
Diluted EPS (ttm)0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)498.16M
Total cash per share (mrq)7.64
Total debt (mrq)418.21M
Total debt/equity (mrq)133.19%
Current ratio (mrq)4.05
Book value per share (mrq)4.82

Cash flow statement

Operating cash flow (ttm)-18.77M
Levered free cash flow (ttm)-39.45M